Islet autoantibodies in clinically diagnosed type 2 diabetes: prevalence and relationship with metabolic control (UKPDS 70) View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2005-04

AUTHORS

T. M. E. Davis, A. D. Wright, Z. M. Mehta, C. A. Cull, I. M. Stratton, G. F. Bottazzo, E. Bosi, I. R. Mackay, R. R. Holman

ABSTRACT

AIMS/HYPOTHESIS: We examined the prevalence of islet autoantibodies and their relationship to glycaemic control over 10 years in patients diagnosed clinically with new-onset type 2 diabetes. METHODS: Patient clinical characteristics and autoantibody status were determined at entry to the UK Prospective Diabetes Study (UKPDS) before randomisation to different glucose control policies. Patients were followed for 10 years. RESULTS: Data available on 4,545 of the 5,102 UKPDS patients showed that 11.6% had antibodies to at least one of three antigens: islet cell cytoplasm, glutamic acid decarboxylase and islet autoantibody 2A (IA-2A). Autoantibody-positive patients were younger, more often Caucasian and leaner, with lower beta cell function and higher insulin sensitivity than autoantibody-negative patients. They also had higher HbA1c, and HDL-cholesterol levels, and lower blood pressure, total cholesterol and plasma triglyceride levels. Despite relative hyperglycaemia, autoantibody-positive patients were less likely to have the metabolic syndrome (as defined by the National Cholesterol Education Program Adult Treatment Program III), reflecting a more beneficial overall risk factor profile. Of 3,867 patients with post-dietary run-in fasting plasma glucose (FPG) values between 6.0 and 14.9 mmol/l and no hyperglycaemic symptoms, 9.4% were autoantibody-positive, compared with 25.1% of 678 patients with FPG values of 15.0 mmol/l or higher, or hyperglycaemic symptoms. In both groups, no differences were seen between those with and without autoantibodies in changes to HbA1c over time, but autoantibody-positive patients required insulin treatment earlier, irrespective of the allocated therapy (p<0.0001). CONCLUSIONS/INTERPRETATION: Autoantibody-positive patients can be treated initially with sulphonylurea, but are likely to require insulin earlier than autoantibody-negative patients. More... »

PAGES

695-702

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00125-005-1690-x

DOI

http://dx.doi.org/10.1007/s00125-005-1690-x

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1050081029

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/15729570


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Autoantibodies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Blood Glucose", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Body Weight", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cholesterol", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Diabetes Mellitus, Type 2", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Diet Therapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Glutamate Decarboxylase", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Glycated Hemoglobin A", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hyperglycemia", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Insulin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lipoproteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Proportional Hazards Models", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Sulfonylurea Compounds", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Time Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Fremantle Hospital", 
          "id": "https://www.grid.ac/institutes/grid.415051.4", 
          "name": [
            "University of Western Australia, School of Medicine and Pharmacology, Fremantle Hospital, P.O. Box 480, 6959, Fremantle, Western Australia, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Davis", 
        "givenName": "T. M. E.", 
        "id": "sg:person.015216203142.77", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015216203142.77"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Queen's Medical Centre", 
          "id": "https://www.grid.ac/institutes/grid.415598.4", 
          "name": [
            "University Hospital, Birmingham, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wright", 
        "givenName": "A. D.", 
        "id": "sg:person.0612622266.32", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0612622266.32"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Oxford University Hospitals NHS Trust", 
          "id": "https://www.grid.ac/institutes/grid.410556.3", 
          "name": [
            "Diabetes Trials Unit, Oxford Centre for Diabetes Endocrinology and Metabolism, University of Oxford, Oxford, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mehta", 
        "givenName": "Z. M.", 
        "id": "sg:person.01322014001.53", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01322014001.53"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Churchill Hospital", 
          "id": "https://www.grid.ac/institutes/grid.415719.f", 
          "name": [
            "Diabetes Trials Unit, Oxford Centre for Diabetes Endocrinology and Metabolism, University of Oxford, Oxford, UK", 
            "Diabetes Trials Unit, OCDEM, Churchill Hospital, Old Road, Headington, OX3 7LJ, Oxford, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cull", 
        "givenName": "C. A.", 
        "id": "sg:person.0637007241.52", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0637007241.52"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Oxford University Hospitals NHS Trust", 
          "id": "https://www.grid.ac/institutes/grid.410556.3", 
          "name": [
            "Diabetes Trials Unit, Oxford Centre for Diabetes Endocrinology and Metabolism, University of Oxford, Oxford, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Stratton", 
        "givenName": "I. M.", 
        "id": "sg:person.01201354332.66", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01201354332.66"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Bambino Ges\u00f9 Paediatric Hospital, Scientific Institute, Rome, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bottazzo", 
        "givenName": "G. F.", 
        "id": "sg:person.0723572726.20", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0723572726.20"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "San Raffaele Hospital", 
          "id": "https://www.grid.ac/institutes/grid.18887.3e", 
          "name": [
            "Diabetes and Endocrinology Unit, San Raffaele Vita-Salute University Hospital, Milan, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bosi", 
        "givenName": "E.", 
        "id": "sg:person.01333476364.42", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01333476364.42"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Monash University", 
          "id": "https://www.grid.ac/institutes/grid.1002.3", 
          "name": [
            "Department of Biochemistry and Molecular Biology, Monash University, 3800, Victoria, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mackay", 
        "givenName": "I. R.", 
        "id": "sg:person.0601576533.64", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0601576533.64"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Oxford University Hospitals NHS Trust", 
          "id": "https://www.grid.ac/institutes/grid.410556.3", 
          "name": [
            "Diabetes Trials Unit, Oxford Centre for Diabetes Endocrinology and Metabolism, University of Oxford, Oxford, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Holman", 
        "givenName": "R. R.", 
        "id": "sg:person.01017043005.08", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01017043005.08"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1136/bmj.321.7258.405", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000154862"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1464-5491.1994.tb02032.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005779148"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1464-5491.1994.tb02032.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005779148"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s001250100602", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008359946", 
          "https://doi.org/10.1007/s001250100602"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s001250100602", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008359946", 
          "https://doi.org/10.1007/s001250100602"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/diab.42.2.359", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011571363"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/bmj.316.7134.823", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012312604"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(98)07019-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018881858"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00400195", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022043816", 
          "https://doi.org/10.1007/bf00400195"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00400195", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022043816", 
          "https://doi.org/10.1007/bf00400195"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00400195", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022043816", 
          "https://doi.org/10.1007/bf00400195"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0168-8227(96)01281-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022887325"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00280883", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027902786", 
          "https://doi.org/10.1007/bf00280883"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00280883", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027902786", 
          "https://doi.org/10.1007/bf00280883"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00280883", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027902786", 
          "https://doi.org/10.1007/bf00280883"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/diacare.26.2.452", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028155316"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1046/j.1464-5491.2000.00359.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031079444"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/jama.285.19.2486", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033739611"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(97)03062-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044239979"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0140-6736(90)90013-u", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047651427"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0140-6736(90)90013-u", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047651427"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/diabetes.52.5.1128", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048102325"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/diacare.26.10.2954", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051024719"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/diabetes.47.12.1857", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1070743744"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/diabetes.48.1.150", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1070743959"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/diacare.18.12.1557", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1070746593"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/diacare.19.1.60", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1070746872"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/diacare.21.12.2191", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1070748075"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.7326/0003-4819-128-3-199802010-00001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1073701989"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082427369", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1083312174", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2005-04", 
    "datePublishedReg": "2005-04-01", 
    "description": "AIMS/HYPOTHESIS: We examined the prevalence of islet autoantibodies and their relationship to glycaemic control over 10 years in patients diagnosed clinically with new-onset type 2 diabetes.\nMETHODS: Patient clinical characteristics and autoantibody status were determined at entry to the UK Prospective Diabetes Study (UKPDS) before randomisation to different glucose control policies. Patients were followed for 10 years.\nRESULTS: Data available on 4,545 of the 5,102 UKPDS patients showed that 11.6% had antibodies to at least one of three antigens: islet cell cytoplasm, glutamic acid decarboxylase and islet autoantibody 2A (IA-2A). Autoantibody-positive patients were younger, more often Caucasian and leaner, with lower beta cell function and higher insulin sensitivity than autoantibody-negative patients. They also had higher HbA1c, and HDL-cholesterol levels, and lower blood pressure, total cholesterol and plasma triglyceride levels. Despite relative hyperglycaemia, autoantibody-positive patients were less likely to have the metabolic syndrome (as defined by the National Cholesterol Education Program Adult Treatment Program III), reflecting a more beneficial overall risk factor profile. Of 3,867 patients with post-dietary run-in fasting plasma glucose (FPG) values between 6.0 and 14.9 mmol/l and no hyperglycaemic symptoms, 9.4% were autoantibody-positive, compared with 25.1% of 678 patients with FPG values of 15.0 mmol/l or higher, or hyperglycaemic symptoms. In both groups, no differences were seen between those with and without autoantibodies in changes to HbA1c over time, but autoantibody-positive patients required insulin treatment earlier, irrespective of the allocated therapy (p<0.0001).\nCONCLUSIONS/INTERPRETATION: Autoantibody-positive patients can be treated initially with sulphonylurea, but are likely to require insulin earlier than autoantibody-negative patients.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s00125-005-1690-x", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1001482", 
        "issn": [
          "0012-186X", 
          "1432-0428"
        ], 
        "name": "Diabetologia", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "4", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "48"
      }
    ], 
    "name": "Islet autoantibodies in clinically diagnosed type 2 diabetes: prevalence and relationship with metabolic control (UKPDS 70)", 
    "pagination": "695-702", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "ee9236ad488ceea47d774db1b91e6736c126d3260ac41d9339e03fddf8d63b7e"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "15729570"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "0006777"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00125-005-1690-x"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1050081029"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00125-005-1690-x", 
      "https://app.dimensions.ai/details/publication/pub.1050081029"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T14:31", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000373_0000000373/records_13093_00000001.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1007%2Fs00125-005-1690-x"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00125-005-1690-x'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00125-005-1690-x'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00125-005-1690-x'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00125-005-1690-x'


 

This table displays all metadata directly associated to this object as RDF triples.

304 TRIPLES      21 PREDICATES      75 URIs      43 LITERALS      31 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00125-005-1690-x schema:about N02fcb33ee0984a3fba70a123102bd589
2 N0c98f97945a043bab6e8bab8c5394e8a
3 N0e1755e04abb49e7aa15901972e17c28
4 N2d37f2c12cb148368e2b2e4addc91f1f
5 N31f9bfe063374319ac48c3a63cf7b341
6 N42341a964d8c490ebca1740d39ac150f
7 N440bdfedfef44558850caf9562d4e9a7
8 N4a628c8e5ecd4b4e9259ffa791fbdc7b
9 N4c76eeda90bb400ead7a7cd26634ea1d
10 N4c904b1bf25a4031bffcc9ab9eb84c65
11 N53fd5141a1e4478987b370d66f6452e5
12 N5486616d2f0b4387acdfe5f2ccb6ef3c
13 N640aa42c8ed547d3bf646c22386cd48f
14 N7b8f0c3bcb5344efb5795d2c787caeb5
15 N8ba2d50a49704191b9f4f7227489e19d
16 N9322d85b76b2448abd27cf4b05d3636e
17 N96b925cd975446b892aacbf9bf485de0
18 N98fcfd57f8d84dd7a8b177d1de1b5aa9
19 Nad6d79acbbad44aca062d5a787c94d72
20 Nb8fef2f59e2a4e8da7baa61d7c11c5fd
21 Nd75cb7e52dfd43f6a0e0b9fb35906dc3
22 Ne1ab05df3c4549cea37cf2b45f2371ae
23 anzsrc-for:11
24 anzsrc-for:1103
25 schema:author Na5d24da066994315bed831951318a3aa
26 schema:citation sg:pub.10.1007/bf00280883
27 sg:pub.10.1007/bf00400195
28 sg:pub.10.1007/s001250100602
29 https://app.dimensions.ai/details/publication/pub.1082427369
30 https://app.dimensions.ai/details/publication/pub.1083312174
31 https://doi.org/10.1001/jama.285.19.2486
32 https://doi.org/10.1016/0140-6736(90)90013-u
33 https://doi.org/10.1016/0168-8227(96)01281-8
34 https://doi.org/10.1016/s0140-6736(97)03062-6
35 https://doi.org/10.1016/s0140-6736(98)07019-6
36 https://doi.org/10.1046/j.1464-5491.2000.00359.x
37 https://doi.org/10.1111/j.1464-5491.1994.tb02032.x
38 https://doi.org/10.1136/bmj.316.7134.823
39 https://doi.org/10.1136/bmj.321.7258.405
40 https://doi.org/10.2337/diab.42.2.359
41 https://doi.org/10.2337/diabetes.47.12.1857
42 https://doi.org/10.2337/diabetes.48.1.150
43 https://doi.org/10.2337/diabetes.52.5.1128
44 https://doi.org/10.2337/diacare.18.12.1557
45 https://doi.org/10.2337/diacare.19.1.60
46 https://doi.org/10.2337/diacare.21.12.2191
47 https://doi.org/10.2337/diacare.26.10.2954
48 https://doi.org/10.2337/diacare.26.2.452
49 https://doi.org/10.7326/0003-4819-128-3-199802010-00001
50 schema:datePublished 2005-04
51 schema:datePublishedReg 2005-04-01
52 schema:description AIMS/HYPOTHESIS: We examined the prevalence of islet autoantibodies and their relationship to glycaemic control over 10 years in patients diagnosed clinically with new-onset type 2 diabetes. METHODS: Patient clinical characteristics and autoantibody status were determined at entry to the UK Prospective Diabetes Study (UKPDS) before randomisation to different glucose control policies. Patients were followed for 10 years. RESULTS: Data available on 4,545 of the 5,102 UKPDS patients showed that 11.6% had antibodies to at least one of three antigens: islet cell cytoplasm, glutamic acid decarboxylase and islet autoantibody 2A (IA-2A). Autoantibody-positive patients were younger, more often Caucasian and leaner, with lower beta cell function and higher insulin sensitivity than autoantibody-negative patients. They also had higher HbA1c, and HDL-cholesterol levels, and lower blood pressure, total cholesterol and plasma triglyceride levels. Despite relative hyperglycaemia, autoantibody-positive patients were less likely to have the metabolic syndrome (as defined by the National Cholesterol Education Program Adult Treatment Program III), reflecting a more beneficial overall risk factor profile. Of 3,867 patients with post-dietary run-in fasting plasma glucose (FPG) values between 6.0 and 14.9 mmol/l and no hyperglycaemic symptoms, 9.4% were autoantibody-positive, compared with 25.1% of 678 patients with FPG values of 15.0 mmol/l or higher, or hyperglycaemic symptoms. In both groups, no differences were seen between those with and without autoantibodies in changes to HbA1c over time, but autoantibody-positive patients required insulin treatment earlier, irrespective of the allocated therapy (p<0.0001). CONCLUSIONS/INTERPRETATION: Autoantibody-positive patients can be treated initially with sulphonylurea, but are likely to require insulin earlier than autoantibody-negative patients.
53 schema:genre research_article
54 schema:inLanguage en
55 schema:isAccessibleForFree true
56 schema:isPartOf Nb371ddae157f4847bf70c68bf19ce019
57 Ne6022577d40046f0b0ae28d647f99701
58 sg:journal.1001482
59 schema:name Islet autoantibodies in clinically diagnosed type 2 diabetes: prevalence and relationship with metabolic control (UKPDS 70)
60 schema:pagination 695-702
61 schema:productId N04a599de0fd54e9c849dcdf4241e9c79
62 N4006c1dff13344fcaeb1ec571b8946be
63 N6e3df47b5ff94d59a580c56f5d8a3561
64 Na55d621829154d5e9e5db8e61eff3f38
65 Nb7ff816bb0fd4f4a910f4c09987cbe00
66 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050081029
67 https://doi.org/10.1007/s00125-005-1690-x
68 schema:sdDatePublished 2019-04-11T14:31
69 schema:sdLicense https://scigraph.springernature.com/explorer/license/
70 schema:sdPublisher N19733761f43e4f7890e453d58b08cf9f
71 schema:url https://link.springer.com/10.1007%2Fs00125-005-1690-x
72 sgo:license sg:explorer/license/
73 sgo:sdDataset articles
74 rdf:type schema:ScholarlyArticle
75 N02fcb33ee0984a3fba70a123102bd589 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
76 schema:name Cholesterol
77 rdf:type schema:DefinedTerm
78 N04a599de0fd54e9c849dcdf4241e9c79 schema:name readcube_id
79 schema:value ee9236ad488ceea47d774db1b91e6736c126d3260ac41d9339e03fddf8d63b7e
80 rdf:type schema:PropertyValue
81 N0c98f97945a043bab6e8bab8c5394e8a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
82 schema:name Body Weight
83 rdf:type schema:DefinedTerm
84 N0e1755e04abb49e7aa15901972e17c28 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
85 schema:name Diet Therapy
86 rdf:type schema:DefinedTerm
87 N19733761f43e4f7890e453d58b08cf9f schema:name Springer Nature - SN SciGraph project
88 rdf:type schema:Organization
89 N2d37f2c12cb148368e2b2e4addc91f1f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
90 schema:name Sulfonylurea Compounds
91 rdf:type schema:DefinedTerm
92 N31f9bfe063374319ac48c3a63cf7b341 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
93 schema:name Autoantibodies
94 rdf:type schema:DefinedTerm
95 N4006c1dff13344fcaeb1ec571b8946be schema:name doi
96 schema:value 10.1007/s00125-005-1690-x
97 rdf:type schema:PropertyValue
98 N42341a964d8c490ebca1740d39ac150f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
99 schema:name Lipoproteins
100 rdf:type schema:DefinedTerm
101 N440bdfedfef44558850caf9562d4e9a7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
102 schema:name Time Factors
103 rdf:type schema:DefinedTerm
104 N4532d030c22845098556f7ab059cd2e2 rdf:first sg:person.0637007241.52
105 rdf:rest Ncdd4c321fd894095ac4124e39ed3ec69
106 N4a628c8e5ecd4b4e9259ffa791fbdc7b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
107 schema:name Middle Aged
108 rdf:type schema:DefinedTerm
109 N4c76eeda90bb400ead7a7cd26634ea1d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
110 schema:name Diabetes Mellitus, Type 2
111 rdf:type schema:DefinedTerm
112 N4c904b1bf25a4031bffcc9ab9eb84c65 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
113 schema:name Insulin
114 rdf:type schema:DefinedTerm
115 N53fd5141a1e4478987b370d66f6452e5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
116 schema:name Treatment Outcome
117 rdf:type schema:DefinedTerm
118 N5486616d2f0b4387acdfe5f2ccb6ef3c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
119 schema:name Adult
120 rdf:type schema:DefinedTerm
121 N5a56c47cd26444839532b9046e2ceee8 rdf:first sg:person.01322014001.53
122 rdf:rest N4532d030c22845098556f7ab059cd2e2
123 N5b451a215aaa4f79843a0d4c2eddbeaf rdf:first sg:person.01333476364.42
124 rdf:rest N8c30b1fbe7364b208e9fabe882081599
125 N640aa42c8ed547d3bf646c22386cd48f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Aged
127 rdf:type schema:DefinedTerm
128 N657516f0d21848b8b209def42546b0a9 schema:name Bambino Gesù Paediatric Hospital, Scientific Institute, Rome, Italy
129 rdf:type schema:Organization
130 N6e3df47b5ff94d59a580c56f5d8a3561 schema:name nlm_unique_id
131 schema:value 0006777
132 rdf:type schema:PropertyValue
133 N7b8f0c3bcb5344efb5795d2c787caeb5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Hyperglycemia
135 rdf:type schema:DefinedTerm
136 N8ba2d50a49704191b9f4f7227489e19d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Male
138 rdf:type schema:DefinedTerm
139 N8c30b1fbe7364b208e9fabe882081599 rdf:first sg:person.0601576533.64
140 rdf:rest Nfe9711497db04058b1784b2d44021e42
141 N9322d85b76b2448abd27cf4b05d3636e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name Proportional Hazards Models
143 rdf:type schema:DefinedTerm
144 N96b925cd975446b892aacbf9bf485de0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
145 schema:name Humans
146 rdf:type schema:DefinedTerm
147 N98fcfd57f8d84dd7a8b177d1de1b5aa9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Prospective Studies
149 rdf:type schema:DefinedTerm
150 Na55d621829154d5e9e5db8e61eff3f38 schema:name pubmed_id
151 schema:value 15729570
152 rdf:type schema:PropertyValue
153 Na5d24da066994315bed831951318a3aa rdf:first sg:person.015216203142.77
154 rdf:rest Nae0760a4592e406798667059bbf0be80
155 Nad6d79acbbad44aca062d5a787c94d72 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Female
157 rdf:type schema:DefinedTerm
158 Nae0760a4592e406798667059bbf0be80 rdf:first sg:person.0612622266.32
159 rdf:rest N5a56c47cd26444839532b9046e2ceee8
160 Nb371ddae157f4847bf70c68bf19ce019 schema:volumeNumber 48
161 rdf:type schema:PublicationVolume
162 Nb7ff816bb0fd4f4a910f4c09987cbe00 schema:name dimensions_id
163 schema:value pub.1050081029
164 rdf:type schema:PropertyValue
165 Nb8fef2f59e2a4e8da7baa61d7c11c5fd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
166 schema:name Glycated Hemoglobin A
167 rdf:type schema:DefinedTerm
168 Ncdd4c321fd894095ac4124e39ed3ec69 rdf:first sg:person.01201354332.66
169 rdf:rest Nfb159dd48e23478dac4514935677447d
170 Nd75cb7e52dfd43f6a0e0b9fb35906dc3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
171 schema:name Blood Glucose
172 rdf:type schema:DefinedTerm
173 Ne1ab05df3c4549cea37cf2b45f2371ae schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
174 schema:name Glutamate Decarboxylase
175 rdf:type schema:DefinedTerm
176 Ne6022577d40046f0b0ae28d647f99701 schema:issueNumber 4
177 rdf:type schema:PublicationIssue
178 Nfb159dd48e23478dac4514935677447d rdf:first sg:person.0723572726.20
179 rdf:rest N5b451a215aaa4f79843a0d4c2eddbeaf
180 Nfe9711497db04058b1784b2d44021e42 rdf:first sg:person.01017043005.08
181 rdf:rest rdf:nil
182 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
183 schema:name Medical and Health Sciences
184 rdf:type schema:DefinedTerm
185 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
186 schema:name Clinical Sciences
187 rdf:type schema:DefinedTerm
188 sg:journal.1001482 schema:issn 0012-186X
189 1432-0428
190 schema:name Diabetologia
191 rdf:type schema:Periodical
192 sg:person.01017043005.08 schema:affiliation https://www.grid.ac/institutes/grid.410556.3
193 schema:familyName Holman
194 schema:givenName R. R.
195 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01017043005.08
196 rdf:type schema:Person
197 sg:person.01201354332.66 schema:affiliation https://www.grid.ac/institutes/grid.410556.3
198 schema:familyName Stratton
199 schema:givenName I. M.
200 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01201354332.66
201 rdf:type schema:Person
202 sg:person.01322014001.53 schema:affiliation https://www.grid.ac/institutes/grid.410556.3
203 schema:familyName Mehta
204 schema:givenName Z. M.
205 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01322014001.53
206 rdf:type schema:Person
207 sg:person.01333476364.42 schema:affiliation https://www.grid.ac/institutes/grid.18887.3e
208 schema:familyName Bosi
209 schema:givenName E.
210 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01333476364.42
211 rdf:type schema:Person
212 sg:person.015216203142.77 schema:affiliation https://www.grid.ac/institutes/grid.415051.4
213 schema:familyName Davis
214 schema:givenName T. M. E.
215 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015216203142.77
216 rdf:type schema:Person
217 sg:person.0601576533.64 schema:affiliation https://www.grid.ac/institutes/grid.1002.3
218 schema:familyName Mackay
219 schema:givenName I. R.
220 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0601576533.64
221 rdf:type schema:Person
222 sg:person.0612622266.32 schema:affiliation https://www.grid.ac/institutes/grid.415598.4
223 schema:familyName Wright
224 schema:givenName A. D.
225 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0612622266.32
226 rdf:type schema:Person
227 sg:person.0637007241.52 schema:affiliation https://www.grid.ac/institutes/grid.415719.f
228 schema:familyName Cull
229 schema:givenName C. A.
230 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0637007241.52
231 rdf:type schema:Person
232 sg:person.0723572726.20 schema:affiliation N657516f0d21848b8b209def42546b0a9
233 schema:familyName Bottazzo
234 schema:givenName G. F.
235 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0723572726.20
236 rdf:type schema:Person
237 sg:pub.10.1007/bf00280883 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027902786
238 https://doi.org/10.1007/bf00280883
239 rdf:type schema:CreativeWork
240 sg:pub.10.1007/bf00400195 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022043816
241 https://doi.org/10.1007/bf00400195
242 rdf:type schema:CreativeWork
243 sg:pub.10.1007/s001250100602 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008359946
244 https://doi.org/10.1007/s001250100602
245 rdf:type schema:CreativeWork
246 https://app.dimensions.ai/details/publication/pub.1082427369 schema:CreativeWork
247 https://app.dimensions.ai/details/publication/pub.1083312174 schema:CreativeWork
248 https://doi.org/10.1001/jama.285.19.2486 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033739611
249 rdf:type schema:CreativeWork
250 https://doi.org/10.1016/0140-6736(90)90013-u schema:sameAs https://app.dimensions.ai/details/publication/pub.1047651427
251 rdf:type schema:CreativeWork
252 https://doi.org/10.1016/0168-8227(96)01281-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022887325
253 rdf:type schema:CreativeWork
254 https://doi.org/10.1016/s0140-6736(97)03062-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044239979
255 rdf:type schema:CreativeWork
256 https://doi.org/10.1016/s0140-6736(98)07019-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018881858
257 rdf:type schema:CreativeWork
258 https://doi.org/10.1046/j.1464-5491.2000.00359.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1031079444
259 rdf:type schema:CreativeWork
260 https://doi.org/10.1111/j.1464-5491.1994.tb02032.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1005779148
261 rdf:type schema:CreativeWork
262 https://doi.org/10.1136/bmj.316.7134.823 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012312604
263 rdf:type schema:CreativeWork
264 https://doi.org/10.1136/bmj.321.7258.405 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000154862
265 rdf:type schema:CreativeWork
266 https://doi.org/10.2337/diab.42.2.359 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011571363
267 rdf:type schema:CreativeWork
268 https://doi.org/10.2337/diabetes.47.12.1857 schema:sameAs https://app.dimensions.ai/details/publication/pub.1070743744
269 rdf:type schema:CreativeWork
270 https://doi.org/10.2337/diabetes.48.1.150 schema:sameAs https://app.dimensions.ai/details/publication/pub.1070743959
271 rdf:type schema:CreativeWork
272 https://doi.org/10.2337/diabetes.52.5.1128 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048102325
273 rdf:type schema:CreativeWork
274 https://doi.org/10.2337/diacare.18.12.1557 schema:sameAs https://app.dimensions.ai/details/publication/pub.1070746593
275 rdf:type schema:CreativeWork
276 https://doi.org/10.2337/diacare.19.1.60 schema:sameAs https://app.dimensions.ai/details/publication/pub.1070746872
277 rdf:type schema:CreativeWork
278 https://doi.org/10.2337/diacare.21.12.2191 schema:sameAs https://app.dimensions.ai/details/publication/pub.1070748075
279 rdf:type schema:CreativeWork
280 https://doi.org/10.2337/diacare.26.10.2954 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051024719
281 rdf:type schema:CreativeWork
282 https://doi.org/10.2337/diacare.26.2.452 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028155316
283 rdf:type schema:CreativeWork
284 https://doi.org/10.7326/0003-4819-128-3-199802010-00001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1073701989
285 rdf:type schema:CreativeWork
286 https://www.grid.ac/institutes/grid.1002.3 schema:alternateName Monash University
287 schema:name Department of Biochemistry and Molecular Biology, Monash University, 3800, Victoria, Australia
288 rdf:type schema:Organization
289 https://www.grid.ac/institutes/grid.18887.3e schema:alternateName San Raffaele Hospital
290 schema:name Diabetes and Endocrinology Unit, San Raffaele Vita-Salute University Hospital, Milan, Italy
291 rdf:type schema:Organization
292 https://www.grid.ac/institutes/grid.410556.3 schema:alternateName Oxford University Hospitals NHS Trust
293 schema:name Diabetes Trials Unit, Oxford Centre for Diabetes Endocrinology and Metabolism, University of Oxford, Oxford, UK
294 rdf:type schema:Organization
295 https://www.grid.ac/institutes/grid.415051.4 schema:alternateName Fremantle Hospital
296 schema:name University of Western Australia, School of Medicine and Pharmacology, Fremantle Hospital, P.O. Box 480, 6959, Fremantle, Western Australia, Australia
297 rdf:type schema:Organization
298 https://www.grid.ac/institutes/grid.415598.4 schema:alternateName Queen's Medical Centre
299 schema:name University Hospital, Birmingham, UK
300 rdf:type schema:Organization
301 https://www.grid.ac/institutes/grid.415719.f schema:alternateName Churchill Hospital
302 schema:name Diabetes Trials Unit, OCDEM, Churchill Hospital, Old Road, Headington, OX3 7LJ, Oxford, UK
303 Diabetes Trials Unit, Oxford Centre for Diabetes Endocrinology and Metabolism, University of Oxford, Oxford, UK
304 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...